软件开发

Search documents
电商社交APP开发全流程解析
Sou Hu Cai Jing· 2025-09-30 12:34
在"社交+电商"的模式下,用户购物体验不再局限于浏览和下单,而是通过互动、分享和推荐实现更强的黏性和转化。一个完整的电商社交APP开发流程大 致可以分为以下几个阶段。 电商社交APP开发 用户端:注册登录、商品浏览、购物车、支付、订单管理、好友互动、内容分享。 社交端:动态发布、点赞评论、私信、圈子、直播互动。 商家端:商品管理、订单处理、活动配置、数据统计。 后台端:用户管理、内容审核、数据分析。 在功能明确后,产品经理需绘制原型,UI设计师则将其转化为直观界面,确保既具备购物的便捷性,又能体现社交的趣味性。 三、开发与测试阶段 开发团队通常会先构建最小可行产品(MVP),上线核心功能以快速验证市场。研发过程中要注重交互体验和性能稳定,同时保证支付及用户隐私的安 全。测试环节包括功能测试、性能测试、安全测试和兼容性测试,确保产品在不同设备和网络环境下都能顺畅运行。 一、需求分析与产品定位 在开发之前,首先要明确产品定位。与传统电商平台相比,电商社交APP更强调人与人之间的互动。企业需要结合目标用户群体,确定主要场景和核心卖 点。例如,年轻人偏爱社区分享、兴趣圈子和拼团;部分用户则更青睐达人推荐和直播带货。清 ...
跨平台APP开发有哪些?主流方案对比+鸿蒙/信创适配新选择
Sou Hu Cai Jing· 2025-09-30 12:22
在企业数字化转型进程中,多终端适配已成为刚需——用户可能在手机、电脑、电视甚至车载设备上使 用APP,而传统"一套代码仅适配单一平台"的开发模式,不仅会让企业承担重复开发的高成本,还可能 因迭代速度慢错过市场机会。那么,当前主流的跨平台APP开发方案有哪些?不同方案各有什么特点? 尤其是在鸿蒙原生、信创适配需求日益迫切的当下,企业该如何选择更贴合长期发展的工具?今天就为 大家详细解析。 一、主流跨平台APP开发方案解析 目前市面上的跨平台APP开发方案,主要围绕"降低多端开发成本、提升适配效率"展开,其中Flutter、 React Native、Taro是较为常见的选择,三者在技术原理、适用场景上各有侧重: Flutter是谷歌推出的跨平台框架,基于Dart语言构建,核心优势在于"接近原生的性能体验"——它通过 自绘引擎渲染界面,避免了传统跨平台方案的"桥接损耗",在动画流畅度、复杂交互场景下表现较好。 不过,Flutter的学习成本相对较高,需要开发者掌握Dart语言,对于已有JavaScript技术栈的团队来说, 或许需要一定时间过渡;且在多终端深度适配方面,比如对部分信创操作系统、低功耗物联网设备的支 ...
晚间公告丨9月30日这些公告有看头
Di Yi Cai Jing· 2025-09-30 11:44
Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [2] - Bee Assistant plans to raise up to 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [3] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [4] Group 2 - Three squirrels received approval from the China Securities Regulatory Commission for H-share issuance, planning to issue up to 81.5483 million shares [5] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [6] - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind and solar energy [7] Group 3 - Sainz's subsidiary plans to invest up to 300 million yuan in the expansion of selection and extraction agents [8] - Hunan YN reported no significant changes in its internal and external operating environment [9] - Electric Power Investment plans to restructure assets and has received a notice from the Shenzhen Stock Exchange to suspend review [10] Group 4 - Guanzhong Ecology is in the planning stage to acquire 51% of Hangzhou Actuary [11] - Aima Technology announced the transfer and suspension of production capacity at its subsidiary in Guangdong [12] - Fosun Pharma's subsidiary received approval for clinical trials of a new drug [13] Group 5 - EVE Battery Investment received a cash dividend of 375 million HKD from its indirect associate, Simoer International [14] - Shanmei International announced a change in its board leadership due to personnel changes [15] - Weiye Co. announced the resignation of its chairman for personal reasons [16] Group 6 - Jiaoda Sinuo's chairman is under detention, and the company has appointed a new acting chairman [17] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [18] - ST Zhengping's stock price has seen an abnormal increase, leading to a suspension for investigation [19] Group 7 - Daqian Ecology's shareholder plans to reduce its stake by up to 3% [20] - Rundat Medical's shareholders plan to collectively reduce their stake by up to 2.99% [21] - Seli Medical's shareholder plans to reduce its stake by up to 2% [22] Group 8 - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [23] - Zhongwu Drone signed a significant contract worth 615 million yuan for drone systems [24]
9月30日晚间重要公告一览
Xi Niu Cai Jing· 2025-09-30 09:29
Group 1 - Double-Helix Pharmaceutical announced that its associate, Changfeng Pharmaceutical, is expected to be listed on the Hong Kong Stock Exchange on October 8, 2025, with a global offering of 41.198 million shares priced at HKD 14.75 each. Double-Helix holds approximately 3.68% of Changfeng's shares, with a lock-up period of 12 months post-listing [1] - Changfeng Pharmaceutical is involved in the pharmaceutical industry, specifically in the research and development of gene-engineered drugs [2] Group 2 - Lio Corporation has submitted an application to the Hong Kong Stock Exchange for issuing H-shares and listing on the main board [3] - Lio Corporation operates in the mechanical manufacturing and digital marketing sectors [3] Group 3 - Changjiang Securities received approval from the China Securities Regulatory Commission to issue corporate bonds totaling no more than CNY 20 billion, valid for 24 months [4] - Changjiang Securities provides services such as securities and futures brokerage, financial product distribution, investment advisory, asset custody, and margin financing [4] Group 4 - Jingye Intelligent plans to acquire 51% of Hefei Shengwen Information Technology for CNY 108 million, focusing on engineering information technology and intelligent products [5][6] - Jingye Intelligent specializes in the research, development, production, and sales of special robots and intelligent equipment systems [6] Group 5 - Aimeike's subsidiary received approval for the registration of Minoxidil topical solution, a non-prescription drug for treating hair loss [7][8] - Aimeike is engaged in the research, development, production, and sales of biomedical materials and biopharmaceuticals [8] Group 6 - Dalian Heavy Industry expects a net profit of CNY 474 million to CNY 508 million for the first three quarters of 2025, representing a year-on-year increase of 19.91% to 28.52% [9] - Dalian Heavy Industry specializes in the design, manufacturing, assembly, and installation of major technical equipment [9] Group 7 - Huayou Cobalt signed supply agreements with LGES for a total of approximately 76,000 tons of ternary precursor products from 2026 to 2030 [10][11] - Huayou Cobalt focuses on the research, manufacturing, and sales of new energy lithium battery materials and cobalt new materials [11] Group 8 - Zhenjiang Co. plans to reduce its shareholding by up to 5.529 million shares, not exceeding 3% of the total share capital, due to personal funding needs [12] - Zhenjiang Co. is involved in the design, processing, and sales of wind power equipment and components [12] Group 9 - Watson Bio's subsidiary received a drug registration certificate for a 13-valent pneumococcal polysaccharide conjugate vaccine for children [14][15] - Watson Bio specializes in the research, development, production, and sales of human vaccines and biopharmaceuticals [15] Group 10 - Yikang Pharmaceutical's major shareholder plans to reduce holdings by up to 42 million shares, not exceeding 2.04% of the total share capital, due to personal funding needs [16] - Yikang Pharmaceutical is engaged in the production and sales of excipients, raw materials, finished drugs, and new energy materials [16] Group 11 - Sichuan Gold's shareholder plans to reduce holdings by up to 7.56 million shares, accounting for 1.80% of the total share capital [19] - Sichuan Gold focuses on the construction, mining, and sales of gold mines [19] Group 12 - Kangchen Pharmaceutical received approval for a clinical trial of an innovative drug for treating advanced esophageal squamous cell carcinoma [20][21] - Kangchen Pharmaceutical specializes in the manufacturing of chemical drug formulations [21] Group 13 - UCloud plans to repurchase shares worth between CNY 8 million and CNY 10 million for employee stock ownership plans [22] - UCloud provides cloud computing services centered on IT infrastructure [22] Group 14 - Woton Technology announced an adjustment to its share repurchase plan, raising the price cap to CNY 60 per share [24] - Woton Technology specializes in the research, manufacturing, and sales of separation membrane products [24] Group 15 - Five Continents Medical announced plans for shareholders to reduce holdings by up to 126,530 shares, accounting for 1.8606% of the total share capital [26] - Five Continents Medical focuses on the research, manufacturing, and sales of disposable sterile infusion medical devices [26] Group 16 - CIMC Group plans to repurchase A-shares with a total amount not exceeding CNY 5 billion [27] - CIMC Group specializes in logistics and energy equipment solutions [27] Group 17 - Zhifei Biological's subsidiary received a drug registration certificate for a trivalent influenza vaccine suitable for individuals aged 3 and above [29][30] - Zhifei Biological is involved in the research, development, production, and sales of vaccines and biological products [30]
软件开发板块9月30日涨1.39%,品茗科技领涨,主力资金净流出7亿元
Zheng Xing Xing Ye Ri Bao· 2025-09-30 08:51
证券之星消息,9月30日软件开发板块较上一交易日上涨1.39%,品茗科技领涨。当日上证指数报收于 3882.78,上涨0.52%。深证成指报收于13526.51,上涨0.35%。软件开发板块个股涨跌见下表: | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 688109 | 品名科技 | 100.60 | 18.60% | 12.55万 | | 12.08亿 | | 688225 | 亚信安全 | 21.90 | 10.16% | 12.12万 | | 2.57亿 | | 681809 | 网达软件 | 23.30 | 10.01% | 25.50万 | | 5.91亿 | | 002298 | 中电鑫龙 | 13.19 | 10.01% | 96.04万 | | 12.43亿 | | 300366 | ST创意 | 6.38 | 7.41% | 37.52万 | | 2.34 Z | | 300925 | 法本信息 | 27.90 | 6.94% | 42.44万 | | 11. ...
莱斯信息涨2.07%,成交额1.66亿元,主力资金净流入50.49万元
Xin Lang Cai Jing· 2025-09-30 05:46
9月30日,莱斯信息盘中上涨2.07%,截至13:23,报90.80元/股,成交1.66亿元,换手率2.87%,总市值 148.43亿元。 截至6月30日,莱斯信息股东户数9573.00,较上期减少2.22%;人均流通股6776股,较上期增加8.34%。 2025年1月-6月,莱斯信息实现营业收入4.57亿元,同比减少28.37%;归母净利润-3126.67万元,同比减 少473.50%。 分红方面,莱斯信息A股上市后累计派现1.32亿元。 资金流向方面,主力资金净流入50.49万元,特大单买入1769.25万元,占比10.65%,卖出2483.91万元, 占比14.95%;大单买入4781.28万元,占比28.77%,卖出4016.14万元,占比24.17%。 莱斯信息今年以来股价涨4.74%,近5个交易日涨2.09%,近20日涨7.32%,近60日涨5.12%。 资料显示,南京莱斯信息技术股份有限公司位于江苏省南京市秦淮区永智路8号,成立日期1988年7月16 日,上市日期2023年6月28日,公司主营业务涉及莱斯信息作为民用指挥信息系统整体解决方案提供商, 主要面向民航空中交通管理、城市道路交通管理以及 ...
博彦科技正式启动“新加坡创新中心”
3 6 Ke· 2025-09-30 05:46
近日,博彦科技在新加坡召开以"让全球市场触手可及(Global Reach Within Your Grasp)"为主题的论 坛。会上,博彦科技宣布正式启动其"新加坡创新中心",并公布了全新的海外投资战略。此外,发布会 现场,博彦科技与美锦能源、文华在线和百胜软件等三家企业正式签署MOU,全面深化战略合作,进 一步佐证了博彦科技在构建共赢生态体系的决心,为后续发展提供了良好的开端。 ...
顶点软件涨2.01%,成交额1.65亿元,主力资金净流出1096.64万元
Xin Lang Zheng Quan· 2025-09-30 05:35
截至6月30日,顶点软件股东户数2.18万,较上期减少10.92%;人均流通股9373股,较上期增加 12.26%。2025年1月-6月,顶点软件实现营业收入2.46亿元,同比减少7.97%;归母净利润5287.79万元, 同比增长8.40%。 分红方面,顶点软件A股上市后累计派现8.14亿元。近三年,累计派现4.90亿元。 机构持仓方面,截止2025年6月30日,顶点软件十大流通股东中,香港中央结算有限公司位居第七大流 通股东,持股225.10万股,相比上期减少43.68万股。华商新趋势优选混合(166301)位居第十大流通股 东,持股120.00万股,为新进股东。华宝中证金融科技主题ETF(159851)退出十大流通股东之列。 责任编辑:小浪快报 资料显示,福建顶点软件股份有限公司位于福建省福州市鼓楼区铜盘路软件大道89号G区8-9号楼顶点 软件金融科技中心,成立日期2000年10月25日,上市日期2017年5月22日,公司主营业务涉及致力于利 用自主研发的"灵动业务架构平台(LiveBOS)",为包括证券、期货、银行、电子交易市场等在内的金融行 业及其他行业提供以业务流程管理(BPM)为核心、以"互联网 ...
9月30日早间重要公告一览
Xi Niu Cai Jing· 2025-09-30 04:10
Group 1 - Pingzhi Information has been selected as the eighth candidate for the "2025 China Unicom General Server Centralized Procurement Project" with a bid amount of approximately 451 million yuan [1] - The project involves the procurement of general servers primarily for cloud computing infrastructure [1] - Pingzhi Information was established in November 2002 and focuses on communication equipment, computing power, and operator equity products [1] Group 2 - Betta Pharmaceuticals has submitted an application for the issuance of H shares and listing on the Hong Kong Stock Exchange [2] - Betta Pharmaceuticals was founded in January 2003 and specializes in the production and sales of innovative drugs [2] Group 3 - Guangli Micro plans to sign an agreement with Zhejiang University to establish a joint research center for silicon photonics technology and measurement equipment [3] - The company will invest no less than 15 million yuan over three years for the center's development [3] - Guangli Micro was founded in August 2003 and provides a range of services including integrated circuit manufacturing and design [3] Group 4 - Shanhe Pharmaceutical's controlling shareholder and actual controller has changed due to the passing of Yin Zhenglong, with his wife and daughter inheriting shares [4] - After the change, Wu Changhong holds 20.172% of the total shares, while Yin Zhiya holds 6.724% [4] - Shanhe Pharmaceutical was established in April 2001 and focuses on the research, production, and sales of pharmaceutical excipients [5] Group 5 - Hengwei Technology plans to acquire 75% of Shanghai Shuhang Information Technology Co., Ltd. through a combination of share issuance and cash payment [6] - The acquisition will make Shuhang Technology a subsidiary of Hengwei Technology [6] - Hengwei Technology was founded in March 2003 and specializes in intelligent system solutions [7] Group 6 - Shougang Co. intends to repurchase its A-shares for an amount between 260 million yuan and 520 million yuan [8] - The repurchase will be used for implementing an equity incentive plan [8] - Shougang Co. was established in October 1999 and focuses on the production and sales of steel products [9] Group 7 - Pulit plans to build a 6GWh sodium-ion battery production base in Sichuan with a total investment of approximately 800 million yuan [10] - The project will be constructed in two phases, with the first phase having a capacity of 2GWh [10] - Pulit was founded in October 1999 and specializes in high polymer new materials and battery production [10] Group 8 - Saisir has proposed a cash dividend of 3.1 yuan per 10 shares for its A-share shareholders [10] - Saisir was established in May 2007 and focuses on the research, manufacturing, and sales of new energy vehicles [10] Group 9 - Guangyang Co. plans to establish a wholly-owned subsidiary for the development of precision components for robots [11] - The investment is part of a project to produce high-end components for new energy vehicles and robots [11] - Guangyang Co. was founded in April 1995 and specializes in precision components for various vehicles and equipment [11] Group 10 - Conch New Materials intends to acquire a 51% stake in North China Industrial Plastics Co., Ltd. for approximately 95.27 million yuan [12] - The acquisition will make North China Plastics a subsidiary of Conch New Materials [12] - Conch New Materials was established in October 1996 and focuses on the production and sales of plastic profiles and aluminum profiles [12] Group 11 - Daikin Heavy Industries has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [13] - The company specializes in the production and sales of offshore wind power equipment [13] - Daikin Heavy Industries was founded in September 2003 [13] Group 12 - Tengya Precision plans to invest up to 8 million USD to establish a subsidiary in Vietnam for the production of garden robots and electric tools [14] - The project will involve leasing a factory in Dong Nai Province [14] - Tengya Precision was established in August 2000 and focuses on power tools and building hardware [15] Group 13 - Luoxin Pharmaceutical plans to raise up to 207 million yuan through a private placement for innovative drug research and development [16] - The funds will primarily support clinical research for specific innovative drugs [16] - Luoxin Pharmaceutical was founded in May 1998 and specializes in pharmaceutical product development [17] Group 14 - *ST Guohua's subsidiary has become the first candidate for a project with a bid of 236 million yuan [18] - The project involves a 90-day construction period [18] - *ST Guohua was established in May 1986 and focuses on mobile network security [19] Group 15 - Su Chen Technology plans to acquire 60% of Likong Technology for a total price of 192 million yuan [20] - The acquisition will make Likong Technology a secondary subsidiary of Su Chen Technology [20] - Su Chen Technology was founded in February 2006 and specializes in CAE software development [21] Group 16 - Qingmu Technology's major shareholder plans to reduce their stake by up to 276,000 shares [22] - The reduction is due to the shareholder's financial needs [22] - Qingmu Technology was established in August 2009 and provides comprehensive e-commerce operation services [23] Group 17 - Tongda Sea plans to acquire 40% of Jiangsu Sufuda Data Technology Co., Ltd. for 25.64 million yuan [24] - The acquisition will result in Tongda Sea holding 100% of Sufuda [24] - Tongda Sea was founded in March 1995 and provides information technology services for electronic government affairs [24] Group 18 - Rongsheng Development has signed a memorandum of cooperation to promote the development of the seaplane industry [25] - The cooperation will focus on infrastructure construction and talent training [25] - Rongsheng Development was established in December 1996 and specializes in real estate development [26] Group 19 - Jinma Amusement plans to repurchase 16.52% of its subsidiary for 60 million yuan [28] - The repurchase will convert the subsidiary into a wholly-owned entity [28] - Jinma Amusement was founded in November 2007 and focuses on amusement facilities and projects [28] Group 20 - Huilv Ecology plans to acquire 49% of Junheng Technology for 1.127 billion yuan [29] - The acquisition will make Junheng Technology a wholly-owned subsidiary [29] - Huilv Ecology was established in January 1990 and specializes in optical communication products and landscape engineering [30]
信安世纪涨2.06%,成交额6611.97万元,主力资金净流入535.40万元
Xin Lang Cai Jing· 2025-09-30 03:05
9月30日,信安世纪盘中上涨2.06%,截至10:43,报14.85元/股,成交6611.97万元,换手率1.49%,总市 值47.10亿元。 资金流向方面,主力资金净流入535.40万元,特大单买入0.00元,占比0.00%,卖出112.65万元,占比 1.70%;大单买入1295.01万元,占比19.59%,卖出646.96万元,占比9.78%。 信安世纪今年以来股价涨68.18%,近5个交易日跌2.94%,近20日涨1.37%,近60日涨14.41%。 今年以来信安世纪已经2次登上龙虎榜,最近一次登上龙虎榜为8月29日,当日龙虎榜净买入4922.44万 元;买入总计8283.68万元 ,占总成交额比13.21%;卖出总计3361.24万元 ,占总成交额比5.36%。 资料显示,北京信安世纪科技股份有限公司位于北京市海淀区建枫路(南延)6号院2号楼1层101,成立日 期2001年8月31日,上市日期2021年4月21日,公司主营业务涉及以密码技术为基础支撑,解决网络环境 中的身份安全、通信安全和数据安全等信息安全问题。主营业务收入构成为:信息安全产品76.97%, 服务23.03%。 信安世纪所属申万行业 ...